Comparison

RAPTA-C European Partner

Item no. TMO-T34262-100mg
Manufacturer TargetMol
CASRN 372948-28-2
Amount 100 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C24H36CL2N5PRu
Smiles [Cl-][Ru+2]12345([Cl-])([CH]=6[CH]5=C4(C(C)C)[CH]3=[CH]2C61C)[P]78CN9CN(CN(C9)C7)C8
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
463.35
Description
RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
Pathways
Apoptosis
Bioactivity
RAPTA-C can induce apoptosis of EAC cells by mitochondrial and p53-JNK pathways.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close